startup.bid
EN
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

WonderTx

Extrapolative AI to unlock First-in-Class drugs

About

We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery.  This should dramatically increase our probability of success.

There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.

Topics

Location
San Francisco, CA, United States
Team size
3 employees
YC batch
Summer 2026
Status
Active
Stage
Early stage

Similar startups & competitors

Questions and answers

What does WonderTx do?

Extrapolative AI to unlock First-in-Class drugs

Where is WonderTx based?

San Francisco, CA, United States

How many people work at WonderTx?

3 employees, according to the company profile.

Has WonderTx raised money?

There are no funding rounds for WonderTx in our data.

What are the alternatives to WonderTx?

Similar startups: Diffuse Bio, Output Labs, and Numerion Labs.